Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Shares Outstanding (Diluted Average) (2020 - 2022)

Historic Shares Outstanding (Diluted Average) for Iterum Therapeutics (ITRM) over the last 3 years, with Q3 2022 value amounting to $12.2 million.

  • Iterum Therapeutics' Shares Outstanding (Diluted Average) fell 927.36% to $12.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $12.2 million, marking a year-over-year decrease of 927.36%. This contributed to the annual value of $10.9 million for FY2021, which is 58042.01% up from last year.
  • Iterum Therapeutics' Shares Outstanding (Diluted Average) amounted to $12.2 million in Q3 2022, which was down 927.36% from $12.2 million recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Shares Outstanding (Diluted Average) registered a high of $204.6 million during Q2 2021, and its lowest value of $1.6 million during Q4 2020.
  • For the 3-year period, Iterum Therapeutics' Shares Outstanding (Diluted Average) averaged around $33.7 million, with its median value being $12.2 million (2022).
  • In the last 5 years, Iterum Therapeutics' Shares Outstanding (Diluted Average) skyrocketed by 121030.23% in 2021 and then crashed by 9402.53% in 2022.
  • Over the past 3 years, Iterum Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $1.6 million in 2020, then surged by 580.42% to $10.9 million in 2021, then increased by 12.32% to $12.2 million in 2022.
  • Its Shares Outstanding (Diluted Average) stands at $12.2 million for Q3 2022, versus $12.2 million for Q2 2022 and $12.2 million for Q1 2022.